Yi Ping Rong
Chief Tech/Sci/R&D Officer en HBM HOLDINGS LIMITED .
Fortuna: - $ al 31/03/2024
Perfil
Yi Ping Rong is currently an Executive Director & Senior Vice President at Harbour BioMed (Shanghai) Co., Ltd.
and an Executive Director, Chief Scientific Officer & SVP at HBM Holdings Ltd.
Dr. Rong previously worked as a Member at The American Association of Cancer Research.
Dr. Rong holds a doctorate degree from Case Western Reserve University, conferred in 2008, and a graduate degree from East China University of Science & Technology, conferred in 2002.
Participaciones conocidas en empresas públicas
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
HBM HOLDINGS LTD.
-.--% | 03/04/2024 | 0 ( -.--% ) | - $ | 31/03/2024 |
Cargos activos de Yi Ping Rong
| Empresas | Cargo | Inicio |
|---|---|---|
| HBM HOLDINGS LIMITED | Chief Tech/Sci/R&D Officer | 05/05/2022 |
Harbour BioMed (Shanghai) Co., Ltd.
 Harbour BioMed (Shanghai) Co., Ltd. BiotechnologyHealth Technology Harbour Biomed Shanghai Co. Ltd. engages in the development of therapeutics for cancer, especially in immuno-oncology. The company is headquartered in Shanghai, China. | Director/Board Member | - |
Antiguos cargos conocidos de Yi Ping Rong.
| Empresas | Cargo | Fin |
|---|---|---|
| The American Association of Cancer Research | Corporate Officer/Principal | - |
Formación de Yi Ping Rong.
| Case Western Reserve University | Doctorate Degree |
| East China University of Science & Technology | Graduate Degree |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas cotizadas | 1 |
|---|---|
| HBM HOLDINGS LIMITED | Health Technology |
| Empresas privadas | 2 |
|---|---|
Harbour BioMed (Shanghai) Co., Ltd.
Harbour BioMed (Shanghai) Co., Ltd. BiotechnologyHealth Technology Harbour Biomed Shanghai Co. Ltd. engages in the development of therapeutics for cancer, especially in immuno-oncology. The company is headquartered in Shanghai, China. | Health Technology |
| The American Association of Cancer Research |
- Bolsa de valores
- Insiders
- Yi Ping Rong
